CDK2 is required by MYC to induce apoptosis

Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305-5151, USA.
Cell cycle (Georgetown, Tex.) (Impact Factor: 4.57). 07/2006; 5(12):1342-7. DOI: 10.4161/cc.5.12.2859
Source: PubMed


Depending upon the cellular and physiologic context, the overexpression of the MYC proto-oncogene results in rapid cell growth, proliferation, induction of apoptosis and/or proliferative arrest. What determines the precise consequences upon MYC activation is not clear. We have found that cyclin-dependent kinase 2 (CDK2) is required by MYC to induce apoptosis. MYC-induced apoptosis was suppressed in mouse embryonic fibroblasts (MEF) knocked out for Cdk2 or normal human fibroblasts (NHF) upon expression of the CDK2 inhibitor p27 or treated with RNAi directed at CDK2. Knockout of Cdk2 did not prevent MYC from inducing p53 and Bim. The inhibition of CDK2 did not prevent apoptosis induced by the DNA damaging agent etoposide. Our results surprisingly suggest that CDK2 defines whether MYC induction causes apoptosis.

Download full-text


Available from: Philipp Kaldis
  • Source
    • "The latter is activated in keratinocytes treated with PV IgG (Arredondo et al, 2005). While Cdk2 is required by c-Myc to induce apoptosis (Deb-Basu et al, 2006), PV sera are known to cause accumulation of Cdk2, thus contributing to acantholysis in the mouse model of PV (Lanza et al, 2008). A plethora of protein kinases have been reported to mediate, at least in part, the pathogenic effects of PV sera. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oral Diseases (2012) 18, 442–458 Pemphigus vulgaris (PV) is the most common type of pemphigus. PV pathogenesis is still debated, and treatment remains challenging. We investigated five controversial topics: (1) What are the target antigens in PV? (2) Do desmogleins adequately address PV pathophysiology? (3) How does acantholysis occur in PV? (4) Is PV still a lethal disease? (5) What is the role of rituximab (RTX) in PV treatment? Results from extensive literature searches suggested the following: (1) Target antigens of PV include a variety of molecules and receptors that are not physically compartmentalized within the epidermis. (2) PV is caused by a variety of autoantibodies to keratinocyte self-antigens, which concur to cause blistering by acting synergistically. (3) The concept of apoptolysis distinguishes the unique mechanism of autoantibody-induced keratinocyte damage in PV from other known forms of cell death. (4) PV remains potentially life-threatening largely because of treatment side effects, but it is uncertain which therapies carry the highest likelihood of lethal risk. (5) RTX is a very promising treatment option in patients with widespread recalcitrant or life-threatening PV. RTX’s cost is an issue, its long-term side effects are still unknown, and randomized controlled trials are needed to establish the optimal dosing regimen.
    Full-text · Article · Dec 2011 · Oral Diseases
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract: The E2F transcription factor family and survivin play a crucial role in maintaining homeostasis by coupling the vital processes of cell division and apoptosis. Deregulation of E2F or survivin signaling, lead to developmental defects in mice and are hallmarks of virtually every human cancer. Functionally, the mammalian E2F family consists of activators (E2F1-2 and E2F3a) and repressors (E2F3b and E2F4-8), which regulate cellular proliferation, apoptosis and differentiation. E2F7 and E2F8, which are the last two discovered mouse E2F family members, structurally form a sub-class within the repressor E2Fs. E2F7-8 are distinct in having a duplicated DNA binding domain, which is highly conserved across all the E2F family members. Both E2F7 and E2F8 inhibit cellular proliferation when overexpressed in mouse embryonic fibroblasts (MEFs). Expression of E2F7 and E2F8 are cell cycle regulated and are detected in the same adult mouse tissues suggesting a functional overlap or synergy. Consistent with the expanding complexity and functional diversity of the large mammalian E2F family, a cell cycle checkpoint is also regulated by the E2Fs. Simultaneous deletion of E2F1, E2F2 and E2F3, leads to a severe proliferative defect in the MEFs, correlating with the upregulation of p21 and the absence of cyclin dependent kinase activity. A proliferative defect is also observed in the MEFs conditionally deleted for survivin, a direct transcriptional target of the E2Fs. Survivin performs dual functions as a regulator of cell division and as an anti-apoptotic protein. During cell division, survivin ensures high fidelity chromosomal segregation and proper cytokinesis. Accordingly, survivin deleted MEFs fail to proliferate and become increasingly polyploid with an abnormal nuclear morphology. However, they do not undergo apoptosis, indicating a role of survivin in proliferation but not survival. Additionally, MEFs transformed with oncogenes c-Myc and H-RasV12 fail to proliferate following conditional deletion of survivin, demonstrating a requirement for survivin in the maintenance of transformation. Preliminary evidence also suggests that survivin is capable of collaborating with c-Myc or H-RasV12 in transforming MEFs, unraveling a novel role for survivin in cancer initiation. Collectively, these data uncover important roles of the E2F family and survivin in cellular proliferation and transformation. 3.91 MB Title from first page of PDF file. Thesis (Ph. D.)--Ohio State University, 2007. Includes bibliographical references (p. 128-138). Available online via OhioLINK's ETD Center System requirements: World Wide Web browser and PDF viewer.
    Preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Until recently, the p53 transcriptional target p21, a member of the Cip/Kip family, was almost solely viewed as a nuclear protein with a principal function of inhibiting cyclin-dependent kinase (CDK) activity and hence, cell cycle progression. However, emerging evidence now suggests additional functions for p21 in diverse cellular processes including a role as a modulator of apoptosis. Several mechanisms are suggested by which p21 interferes with the apoptotic machinery that encompass either CDK-independent events such as transcriptional regulation and direct binding to pro-apoptotic gene products in the cytoplasm, or that were based on inhibition of CDKs that in several studies were required downstream of caspases for the generation of characteristic apoptotic alterations. Very recently, we have shown that p21 protects cells from irradiation-induced apoptosis by suppression of CDK activity that appears to be required downstream of the mitochondria for an efficient activation of the caspase cascade. Together with other reports, our results not only demonstrate the close connection of events leading to either cell cycle arrest or apoptosis, but also indicate that the CDK inhibitor p21 battles apoptosis at multiple frontiers.
    Full-text · Article · Mar 2007 · Cell cycle (Georgetown, Tex.)
Show more